Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 0.175M
June 30, 2026 -108.07M
March 31, 2026 -31.44M
December 31, 2025 2.081M
September 30, 2025 1.743M
June 30, 2025 8.757M
March 31, 2025 7.191M
December 31, 2024 -3.151M
September 30, 2024 12.91M
June 30, 2024 6.907M
March 31, 2024 5.77M
December 31, 2023 8.262M
September 30, 2023 8.312M
June 30, 2023 19.53M
Date Value
March 31, 2023 2.312M
December 31, 2022 16.04M
September 30, 2022 8.517M
June 30, 2022 13.20M
March 31, 2022 12.19M
December 31, 2021 5.612M
September 30, 2021 -0.482M
June 30, 2021 -147.76M
March 31, 2021 -0.487M
December 31, 2020
September 30, 2020
June 30, 2020 -0.199M
March 31, 2020 -0.052M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Cypherpunk Technologies, Inc. -6.00M
Zymeworks, Inc. -386.22M
Rhythm Pharmaceuticals, Inc. -16.11M
Cue Biopharma, Inc. 0.00
Yarrow Bioscience, Inc. -5.00M